Gilead Sciences (GILD)
Add to Watchlists Create an Alert
55.64
+0.16 +0.29%
NASDAQ
May 24, 11:37AM
BATS Real time
Currency in USD
Gilead Sciences Free Cash Flow:
435.86M for Dec. 31, 2012Gilead Sciences Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 435.86M |
| Sept. 30, 2012 | 678.78M |
| June 30, 2012 | 1.253B |
| March 31, 2012 | 429.77M |
| Dec. 31, 2011 | 952.00M |
| Sept. 30, 2011 | 832.82M |
| June 30, 2011 | 916.62M |
| March 31, 2011 | 805.67M |
| Dec. 31, 2010 | 701.48M |
| Sept. 30, 2010 | 728.62M |
| June 30, 2010 | 683.03M |
| March 31, 2010 | 658.90M |
| Dec. 31, 2009 | 928.29M |
| Sept. 30, 2009 | 842.41M |
| June 30, 2009 | 602.04M |
| March 31, 2009 | 477.26M |
| Dec. 31, 2008 | 543.10M |
| Sept. 30, 2008 | 480.65M |
| June 30, 2008 | 415.87M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
GILD Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Bristol-Myers Squibb | -543.00M |
| Amgen | 891.00M |
| Celgene Corporation | 341.20M |
GILD Free Cash Flow Rankings
| Overall |
98th percentile 158 of 8009 |
| Sector |
96th percentile 21 of 687 in Healthcare |
| Industry |
98th percentile 3 of 248 in Biotechnology |
GILD Free Cash Flow Range, Past 5 Years
| Minimum | 415.87M | Jun 2008 |
| Maximum | 1.253B | Jun 2012 |
| Average | 703.50M |
